Program Overview
Safer Opioid Prescribing Protocol (SOPP) is a best practice alert (BPA) digital procedural intervention for prescription opioid overdose prevention, patient opioid education, and promotion of naloxone coprescription.
The SOPP intervention integrates into a pre-existing electronic health record (EHR), through which it sends electronic best practice alerts (BPAs) to prescribers and nurses to promote safe opioid prescription practices. To inform and reduce high-dose opioid prescription, SOPP assigns the EHR of each patient an opioid risk factor score (based on comorbidities, coprescription risks, dose level, illicit drug use, previous substance use treatment, and previous opioid overdose events in the past 12 months). When a patient receives a prescription for opioid medication, a SOPP BPA alerts the prescriber and shows a precalculated table of the maximum morphine milligram equivalent (MME) value of opioid safe for that patient at discharge. SOPP then asks the prescriber to indicate whether the prescribed discharge dose is ≥ 100 MME. If the discharge dose is ≥ 100 MME or the patient has a high opioid risk factor score, SOPP advises the prescriber to coprescribe naloxone. If the prescriber declines to coprescribe the patient naloxone, SOPP requires the prescriber to supply justification. Nurses receive up to 2 BPAs at discharge: BPA 1 reminds the nurse to teach the patient about safe opioid medication use. If the patient receives a naloxone coprescription, BPA 2 prompts the nurse to print a prepared patient education brochure on overdose identification/naloxone administration and instruct the patient (and family members) with a preassembled naloxone demonstration kit. SOPP also includes patient brochures with standardized instructions on safe use, storage, and disposal of opioid medications. All SOPP educational materials are available in English, Spanish, and Portuguese.
Delivery:
Computer-based
Theoretical Approach(es):
Brief Intervention (BI)
Best Practice Alerts (BPA)
Target Substance(s):
Opioids
Naloxone
Non-Narcotics
Target Outcome(s):
Overdose Prevention
Ages:
Young Adults
Adults
Genders:
Male
Female
Races/Ethnicities:
Unspecified
Setting(s):
Clinic
Urban
Geographic Location(s):
New England
Country:
United States
Language:
English